Meridian and Earth draft a shared longevity dataset — with nine pages missing

The framework on the table this week does something no longevity dispute has managed before. It proposes a dataset that belongs to no one — held by neither party, examined by both. By the standard of this quarrel, that's an outbreak of adulthood.

It is also, on close reading, a document built around a hole.

The hole is nine pages long. They're the sealed medical record of a retired desalination engineer from Meridian's first cohort, one of a hundred and forty, who ran an unexplained fever that resolved and has stayed resolved. Earth's board has asked for those pages four times. The directorate has said no four times. The joint-audit draft would open the protocols, the cohort markers, the adverse-event logs (of which the completed cohorts report none). It would not open the file.

"A shared dataset is not a confession," said a directorate spokeswoman, briefing reporters in one of Meridian's garden-ring conference rooms. "We are offering to be examined. We are not offering to be governed. Those are different sentences, and Earth keeps trying to read them as one."

That's the whole dispute in a phrase. Meridian built its longevity industry because its charter lets it regulate itself faster and cheaper than Earthside caution allows. A jointly owned dataset is a small surrender of that sovereignty, a stranger's hand on the colony's own labs. The directorate is trying to price that surrender by the page. The fever file is where it has drawn the line.

Earth's regulators find the arithmetic backward. "We are being asked to certify the safety of a therapy we have never once been permitted to see," a board member told the Dispatch, requesting anonymity because the framework is unsigned. "They will show us the clean cohorts and seal the anomaly. That is not an audit. That is a sales brochure with footnotes."

The chart tells a more complicated story than either brief wants to admit. Two cohorts of a hundred and thirty-nine each completed thirty days with clean markers and no sealed files at all. The third finished its first month just as clean. On the numbers, Meridian is winning the argument it wants to have. The trouble is the one file it won't surrender, and the fact that a single sealed anomaly unsettles regulators more than three quiet cohorts reassure them. A resolved fever in one patient of four hundred and eighteen is, clinically, close to noise. Noise you refuse to hand over stops being noise. That's not cynicism. That's just what a chart does when you try to make it lie by omission.

Neither the framework nor the fever will be settled by the time it matters most. A fourth charter, a hundred and thirty-nine paying passengers, last berth sold weeks ago, departs for Meridian in sixty-one days. It arrives whether or not a single page is unsealed. The negotiators know this. So do the passengers.

"We would prefer to arrive to a signed audit," one of them said, reached before departure. "We are arriving either way."